Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MeMuRu-OKA vs Separate MMR and Varicella Vaccines as Second Dose
NCT00352898Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of GSK208136 in measles, mumps, rubella, varicella (VZV), sponsored by GSK. Started Apr 2006; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00352898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352898.